No antimicrobial resistance research agenda without tuberculosis

The global fight against antimicrobial resistance (AMR) needs a unified, multidisciplinary, and intersectoral approach by a community of stakeholders and implementers working towards common goals. As such, the impetus created by the WHO priority list of antibiotic-resistant bacteria1 and increasing focus from the international public health community are timely. However, tuberculosis is not sufficiently emphasised in the AMR discussion at the highest decision-making level. Tuberculosis is the top infectious disease killer globally,2 and is responsible for around a quarter of all deaths caused by AMR bacteria,3 with nearly half a million estimated multidrug-resistant tuberculosis cases annually.